Monday, December 6, 2021
ADVT 
Health

News of potential COVID vaccine 'encouraging': PM

Darpan News Desk The Canadian Press, 09 Nov, 2020 06:07 PM
  • News of potential COVID vaccine 'encouraging': PM

Prime Minister Justin Trudeau says he hopes to see COVID-19 vaccines roll out in Canada early next year, but warns that won't bring an immediate resolution to the pandemic currently seeing a resurgence in several provinces.

The prime minister says news from Pfizer today that one of its vaccine candidates appears very effective in clinical trials is "very encouraging" but won't help anyone who catches the virus in the meantime.

Speaking in Ottawa, Trudeau said other vaccine candidates have also appeared to progress well.

His comments come after a weekend that saw the two provinces hardest hit by the pandemic report record-breaking daily case counts.

Quebec reported 1,397 new cases on Sunday and Ontario reported 1,328, nearly 200 more than the record it had set the previous day.

The number of new infections stayed above 1,000 in Ontario on Monday, with 1,242 reported.

Canada has bought the rights to 20 million doses of Pfizer's vaccine, if it proves effective and Health Canada approves it for use here, and Trudeau said the government would purchase more if the initial round goes well.

The company said in a news release that early results from a large-scale trial show its vaccine is 90 per cent effective at combating the virus.

Tedros Adhanom Ghebreyesus with the World Health Organization also reacted to the good news via Twitter.

"We hope to see vaccines landing in the early next year but between now and then it's really really important that we double down on our efforts," Trudeau said.

"We need to make sure we are controlling the spread of COVID-19 in the coming months so that when vaccines get here we will be able to act quickly to protect all Canadians."

MORE Health ARTICLES

FDA panel urges rejection of experimental Alzheimer's drug

FDA panel urges rejection of experimental Alzheimer's drug

Friday’s meeting follows months of skepticism about the drug, developed by Cambridge, Massachusetts-based Biogen Inc. and Japan’s Eisai Co.

FDA panel urges rejection of experimental Alzheimer's drug

Health Canada approves first HIV self-test

Health Canada approves first HIV self-test

Health Canada granted a medical device licence on Monday to a one-minute, finger-prick blood test manufactured by Richmond, B.C.-based bioLytical Laboratories.

Health Canada approves first HIV self-test

Cost of cancer drugs triples in Canada

Cost of cancer drugs triples in Canada

The Patented Medicine Prices Review Board has released data showing cancer medications account for about 15 per cent of all spending on pharmaceuticals.

Cost of cancer drugs triples in Canada

Health panel proposes colon cancer tests start at 45, not 50

Health panel proposes colon cancer tests start at 45, not 50

While overall, colon cancer rates have been declining, the draft guidelines issued Tuesday by the U.S. Preventive Services Task Force reflect a growing concern about rising rates in people under the age of 50.

Health panel proposes colon cancer tests start at 45, not 50

Mild to severe: Immune system holds clues to virus reaction

Mild to severe: Immune system holds clues to virus reaction

There are two main arms of the immune system. Innate immunity is the body’s first line of defence.

Mild to severe: Immune system holds clues to virus reaction

How can I volunteer for a COVID-19 vaccine study?

How can I volunteer for a COVID-19 vaccine study?

Enthusiasm is high: More than 400,000 people have signed a registry of possible volunteers that’s part of a vaccine network set up by the U.S. National Institutes of Health.

How can I volunteer for a COVID-19 vaccine study?

PrevNext